Abstract. The MT3 specificity is closely associated with the HLA-DR4, DR7, and DRw9, and is a supertypic specificity. To determine whether the MT3 specificity resides on a novel class II antigen, the MT3 antigen, DR antigen and the DC-like antigen from the DR4-, DR7-and DRw9-homozygous B lymphoid cell lines were identified and compared with one another by two-dimensional gel electrophoresis using alloantisera. The analysis revealed that each of the three antigens exists as a structurally distinct class II antigen in each cell line. The light chains of the MT3, DR and DC-like antigens are different in charge from one another. The molecular weight of the heavy chains of the MT3 and DR antigens is higher than that of the DC-like antigen. On the other hand, no electrophoretic differences are observed between the heavy chains of the MT3 and DR antigens. These results strongly suggest that the MT3 specificity resides on a light chain of a novel class II antigen distinct from the DR antigen and the DC-like antigen. These observations also support our previous proposition that the MT3 antigen belongs to the fourth group of the human class II antigens.
Introduction
The class II antigens of the major histocompatibility complex (MHC) play an important role in a number of immune phenomena such as T cell-macrophage interaction (Geha et at. 1979) . The antigens consist of two noncovalently associated glycoproteins, a heavy (alpha) chain with an approximate mol. wt. of 34 000 and a light (beta) chain with an approximate mol. wt. of 29 000 (Shackelford et al. 1982) . The I region of the murine MHC (H-2) encodes at least two class II antigens, I-A and Addressfi)r offprint requests: Dr. Hideo Hamaguchi, Department of Human Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Niihari-gun, Ibaraki 305, Japan.
Y. Yabe et al. I-E. These two antigens are not only structurally distinct but also functionally different (Murphy 1981) . In man, the HLA-D/DR region is analogous to the murine I region and encodes at least three class II antigens: DR, SB, and DC , The DR antigen is the homologue of the murine I-E antigen (Shackelford et al. 1982 ) and ten DR alloantigens (DR1-DRwl0) have been defined by serological methods (HLA Nomenclature Committee 1980) . The SB antigen detected primarily by the primed lymphocyte test (PLT) also has an I-E-like structure (Hurley et al. 1982 ) and maps to the region between the DR and GLO loci (Shaw et al. 1981) . The DC locus products have been shown to be the human homologue of the murine I-A antigen (Bono and Strominger 1982 , Goyert et al. 1982 . The DC1 (MB 1, MT1), MB2 (DC3), MB3, and DS (Goyert et al. 1982) antigens are probably allelic products of the DC locus Tosi 1982, Goyert and .
MT3 is a common class II antigen in various human populations: the frequencies of the MT3 phenotype are 0.491 in Caucasians, 0.361 in Negroes and 0.690 in Japanese (Tosi 1981) . The MT3 antigenic specificity is strongly associated with DR4, DRT, and DRw9 but not with the other DR types (Tanigaki et al. 1983) . No recombination has been reported between the MT3 and DR specificities, suggesting that the MT3 specificity does not reside on the SB antigen. However, it is controversial as to whether the MT3 specificity is located on a novel class II antigen distinct from the DR and DC antigens. Goyert and Silver (1983) reported that the MT3 determinant resides on a DR7-1ike molecule in a DR7 cell line and on a DS (DC) molecule in a DR4 cell line. Hurley and co-workers (1983) suggested that the MT3 determinant is present on both the DR-and DS (DC)-like molecules in a DR4 cell line. On the other hand, Katagiri and co-workers (1979) and Tanigaki and coworkers (1983) have shown that the MT3 (HonT, BR4 x 7) antigen is distinct from the DR and DC molecules in the DR4 and DR7 cell lines. Recently, we also have shown, using two-dimensional (2-D) gel electrophoresis and alloantisera, that the light chain of the MT3 antigen is distinct from that of the DR4 antigen in a DR4-homozygous cell line (Suzuki et al. 1983) . It is important to elucidate whether the MT3 specificity resides on a novel class II antigen, because if it does, the MT3 antigen belongs to the fourth group of the human class II antigens.
In this paper, we provide evidence that the MT3 antigen is a novel class II antigen distinct from the DR antigen and DC-like antigen in the DR4, DR7, and DRw9 cell lines.
Materials and Methods
Cell lines. Transformed human B lymphoid cell lines were used. Their HLA phenotypes are given in Table 1 . L-Pitot and L-KT12 were kind gifts from Dr. N. Kashiwagi, Kitasato University, Sagamihara, and ER was kindly provided by Dr. T. Sasazuki, Tokyo Medical and Dental University, Tokyo. The cells were maintained in RPMI-1640 (Gibco, Co., Grand Island, New York) medium supplemented with 10~ heat-inactivated fetal bovine serum.
Amisera. Alloantisera 070701 (anti-DR7), 070702 (anti-DR7), and DKA11 (anti-MT3) were purchased from Hoechst Japan Co., Tokyo. Alloantisera 111634 (anti-DR7) and 111742 (anti-MT3) were purchased from Biotest-Serum-Institute GmbH, Frankfurt, Federal Republic of Germany. Alloantiserum TD148 (anti-MT3) was kindly provided by Dr. H. Maeda, Tokyo University Hospital, Tokyo. Alloantisera Dally (anti-DR7), Schlict (anti-DR7 and MB2), and Chancy (anti-MB2) were kind gifts from Dr. R.J.
The MT3 Antigen Is a Novel Human Class II Antigen The serological speciflcities of some anti-MT3 sera and anti-TB21 scra were described previously (Suzuki et al. 1983, Maeda and Juji t982) . The anti-MB2 serum (anti-DC3 serum) recognizes the DC antigen (Tanigaki and Tosi 1982) . The anti-TB21 serum recognizes the DC-like antigen, as described in the Discussion.
Preparation of labeled membrane glycoproteins. Labeled membrane glycoproteins were prepared as described previously (Suzuki et al. 1983) . Briefly, membranes were isolated by differential centrifugation from about 2.5 x 109 cells. The isolated membranes were solubilized with 2% Nonidet P-40 (NP-40) in 0.1 M Tris-HC1, pH 7.8. The solubilized material was applied to lentil-lectin affinity chromatography and the glycoprotein fraction was eluted with 2% ~-methyl-D-mannoside in 0.02 M Tris-HC1, pH 7.6, 0.15 M NaC1 containing 0.2% NP-40. The glycoprotein fraction was labeled with lzsI by the chloramine T method and used as labeled membrane glycoproteins.
lmmunoprecipitation and electrophoresis. Immunoprecipitation was performed as described previously (Suzuki et al. 1983) . Briefly, labeled membrane glycoproteins were absorbed with a mouse antihuman beta-2 microglobulin monoclonal antibody (Olac Ltd., Bichester) to remove most of the class I antigens. An aliquot (5-10 gl) of the class II antigen-enriched fraction was mixed with 30 gl of alloantiserum and incubated at 4 °C for overnight. Then 20 gl of Protein A-Sepharose CL-4B was added to the reaction mixture. The resulting immunoprecipitate was subjected to electrophoresis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was done according to Laemmli (1970) using the gel with 9% of acrylamide. 2-D gel electrophoresis was performed with nonequilibrium pH gradient gel electrophoresis (NEPHGE) or isoelectric focusing (IEF) in the first dimension and SDS-PAGE in the second dimension. NEPHGE was performed as described previously (Suzuki et al. 1983 ) and IEF was carried out according to O'FarreI1 (1975) . NEPHGE was done for 3500 V/h and IEF for 5600 V/h. SDS-PAGE in the second dimension was performed on 11% acrylamide gel. Molecular weight (mol. wt.) standards used were phosphorylase b (94000), bovine serum albumin (67000), ovalbumin (43 000), carbonic anhydrase (30000), soybean trypsin inhibitor (20 100), and e-lactalbumin (14 400). 125I-labeled antigens (about 10 000-100 000 cpm) were detected on the gel by autoradiography; Kodak-X-Omat film was exposed to a dried gel at -70 °C for 1-7 days. Unlabeled glycoproteins were detected by Coomassie brilliant blue staining.
Results

Identification of the class II antigens from the DR7-homozygous cell line. To identify
each of the DR7, MT3, and MB2 (DC3) antigens, we incubated lzsI-labeled membrane glycoproteins from the cell line L-Pitot with anti-DR7, anti-MT3, or 158 T. Yabe et aL anti-MB2 sera and analyzed the resulting immunoprecipitate by 2-D gel electrophoresis (first dimension: NEPHGE or IEF) (Fig. 1 ). The NEPHGE gave better resolution for the light chains and the IEF was more suitable for the analysis of the heavy chains. In each of the class II antigens, the light chain is detected as a set of two to three spots ( Fig. 1A-C) . This phenomenon is known to be attributable to both the variability in the sialic acid content and the difference in the oligosaccharide type (Shackelford et al. 1982) . The heavy chains also exist as multiple spots in the IEF (Fig. 1E-G) . The relative density of each of the multiple spots of the heavy chain varied with the alloantiserum even in the same class II antigen (data not shown).
Anti-DR7 serum Dally precipitates only one set of heavy and light chains (Fig. 1A, E) . The other three anti-DR7 sera (070701, 070702, and 111634) also precipitated only the same set of heavy and light chains. However, none of the class II antigens reacted with normal human serum which was used as a control (data not shown). Therefore, these heavy and light chains are considered to be the components of the DR7 antigen. A and E, B and F, and C and G are the immunoprecipitates with the anti-DR7 serum Dally, anti-MT3 serum T675, and anti-MB2 serum Chaney, respectively. D and H are the results of mixed experiments in which the three immunoprecipitates were mixed and co-electrophoresed. In the first dimension, NEPHGE (A-D) or IEF (E-H) was performed. For IEF gels, only the range ofpH 5.0-6.0 is shown. The basic end of the NEPHGE and the IEF gel is on the left and the direction of SDS-PAGE is from top to bottom. Only the range between 25 000 and 40 000 dalton is shown. The alloantiserum T675 precipitates the MT3 antigen together with the DR7 light chain, as described in the Results. DR7H and DR7L, DR7 heavy and light chains; MT3H and MT3L, MT3 heavy and light chains; MB2H and MB2L, MB2 heavy and light chains.
Anti-MT3 serum T675 precipitates one set of heavy and light chains together with the DR7 light chain (Fig. 1B, F) . The other four anti-MT3 sera (DKAll, 111742, TD148, and T1065) also precipitated the same one set of heavy and light chains together with the DR7 light chain. The light chains, except for the DR7 light chain, are precipitated specifically with anti-MT3 sera. The light chain detected with the anti-MT3 serum is different from the DR7 light chain in both molecular weight and isoelectric point(s) (pI). Furthermore, a mixed experiment revealed that the light chain detected with the anti-MT3 serum is identical with the MT3 light chain identified in a DR4-homozygous cell line Wa in our previous study (Suzuki et al. 1983 ). Therefore, this light chain is considered to be the light chain of the MT3 antigen. On the other hand, the heavy chain precipitated with the anti-MT3 serum is indistinguishable from the DR7 heavy chain, as in the case of the MT3 and DR4 heavy chains in the Wa cell (Suzuki et al. 1983 ). The co-precipitation of the DR7 antigen with anti-MT3 sera is probably due to the contamination of a small amount of DR-specific antibody in the anti-MT3 sera, as described in a previous paper (Suzuki et at. 1983) and in the Discussion of this paper.
Anti-MB2 serum Chaney precipitates only one set of heavy and light chains (Fig.  1C, G) . Both the heavy and light chains differ in charge from those of the DR7 and MT3 antigens: the pI of MB2 heavy and light chains are more basic than those of the DR7 and MT3 (Fig. 1D, H) . Figure 1D and 1H also suggest that the tool. wt. of the heavy chain of the MB2 antigen is slightly lower than that of the DR7 and MT3 antigens. The other anti-MB2 serum Schlict also precipitated the same class II antigen. Therefore, these heavy and light chains are considered to be the components of the MB2 antigen.
Thus the DR7, MT3, and MB2 (DC3) antigens of the DR7-homozygous cell line were identified by 2-D gel electrophoresis using alloantisera.
To determine the relative amount of the three class II antigens, the membrane glycoproteins of the L-Pitot cell were subjected to 2-D gel electrophoresis and stained with Coomassie brilliant blue (Fig. 2) . The class I antigens and each of the class I1 antigens were identified by a human fiz-microglobulin-specific monoclonal antibody, and anti-DR7, anti-MT3, and anti-MB2 sera, respectively. The analysis revealed that most of the class II antigens consist of the DR7 and that the amounts of the MT3 and MB2 are very small compared with the DR7. The results also show that the class I and class II antigens are the major components of the membrane glycoproteins.
Identification of the class II antigens from the D Rw9-homozygous cell line. To identify
each of the DRw9, MT3, and TB21 antigens, we incubated 125I-labeled membrane glycoproteins from the cell line L-KT12 with anti-DRw9, anti-MT3, or anti-TB21 sera and analyzed the resulting immunoprecipitate by 2-D gel electrophoresis ( Fig. 3 : NEPHGE; Fig. 4 : IEF) and by SDS-PAGE (Fig. 5) . Anti-DRw9 serum 1993 precipitates only one set of heavy and light chains of the class II antigen (Figs. 3A  and 4A ). The other two anti-DRw9 sera (T1016 and T2758) also precipitated the same set of heavy and light chains but normal human serum did not . Therefore, these heavy and light chains are considered to be the components of the DRw9 antigen.
Anti-MT3 serum T1065 precipitates one set of heavy and light chains together with a trace of the DRw9 light chain (Figs. 3B and 4B) . The other four anti-MT3 sera 160 T. Yabe et al. One hundred and fifty gg of the membrane glycoproteins were subjected to electrophoresis. NEPHGE was performed in the first dimension. The gel was stained by Coomassie brilliant blue. Class IH, class I heavy chains; fi2m, beta-2 microglobulin; K, kilodalton. The other labels are the same as in Figure 1. (DKA11, 111742, TD 148, and T675) also precipitated the same one set of heavy and light chains together with a trace of the DRw9 light chain. The light chains, except the DRw9 light chain, are precipitated specifically with anti-MT3 sera. Therefore, this light chain is considered to be the light chain of the MT3 antigen. It was confirmed by a mixed experiment that the MT3 light chain from the L-KT12 cell is identical with that from the L-Pitot cell in Figure lB . The pI and mol. wt. of the MT3 light chain are different from those of the DRw9 light chain: the pI is more acidic and the mol. wt. is lower in the MT3 light chain (Figs. 3-5) . The very small amount of the DRw9 light chain was probably precipitated by a DR-specific antibody contaminating this serum, as described in the DiscussiOn. Since the amount of the light chain of the DRw9 antigen is extremely small compared with that of the MT3 antigen, most of the heavy chain of the class II antigen in Figure 3B and Figure 4B is considered to consist of the heavy chain of the MT3 antigen. As in the case of the heavy chains of the MT3 and DR7 antigens from the cell line L-Pitot, the pI and mol. wt. of the heavy chain of the MT3 antigen are indistinguishable from those of the DRw9 antigen (Figs. 3-5) . Anti-TB21 serum T2200 precipitates one set of heavy and light chains together with a small amount of the DRw9 light chain (Fig. 3C) . The other anti-TB21 sera (T383 and T1573) also precipitated the same set of heavy and light chains together with a trace of the DRw9 light chain. Anti-DRw9 and anti-MT3 sera and normal human serum do not precipitate the heavy and light chains (Figs. 3A,  B, 4A, B) . Therefore, these heavy and light chains are considered to be the components of the TB21 antigen. The pI of the TB21 light chain is between those of the DRw9 and MT3 light chains (Figs. 3 and 4) . This was confirmed by a mixed experiment (data not shown). The pI of the TB21 heavy chain is more basic than that of the DRw9 and MT3 antigens (Fig. 4C) . In addition, the tool. wt. of the TB21 heavy chain is lower than that of the DRw9 and MT3 heavy chains (Fig. 5) . The TB21 antigen is considered to be the DC-like antigen of this cell line, as described in the Discussion. The presence of a small amount of the DRw9 antigen in the precipitates with anti-TB21 sera is probably due to the contamination of a noncytotoxic DR-specific antibody, as described in the Discussion. Thus the DRw9, MT3, and TB21 antigens of the DRw9-homozygous cell line were identified by 2-D gel electrophoresis using alloantisera.
Identification of the class II antigens fi'om the DR4-homozygous cell line. To identify
each of the DR4, MT3, and TB21 antigens, we incubated 125I-labeled membrane glycoproteins from the cell line ER with the anti-DR4, anti-MT3, or anti-TB21 sera and analyzed the resulting immunoprecipitate by 2-D gel electrophoresis (Fig. 6) . Anti-DR4 serum T2297 precipitates only one set of heavy and light chains of the class II antigen (Fig. 6A ). These chains are considered to be the components of the DR4 antigen in this cell line. Anti-MT3 serum TD 148 also precipitates only one set of heavy and light chains of the class II antigen (Fig. 6 B) . The light chain is different from the DR4 light chain in charge: the pI of the light chain is more acidic than that of the DR4 light chain (Fig. 6A, 6B) . Furthermore, comparison of the position on the 2-D gel revealed that both the heavy and light chains precipitated with the anti-MT3 serum from the ER cell are identical with those of the MT3 antigens from the L-Pitot and L-KT12 cells. Therefore, these heavy and light chains are considered to be the components of the MT3 antigen.
Anti-TB21 serum T2200 precipitates a class II antigen together with the DR4 antigen (Fig. 6C) . The other anti-TB21 serum (T383) also precipitated the same class II antigen but normal human serum did not. The light chain is distinct from the light chains of the DR4 and MT3 antigens and is not contained in the precipitates produced with anti-MT3 and anti-DR4 sera (Fig. 6A-C) . Therefore, the light chain is considered to be the component of the TB21 antigen in this cell line. A comparison of the position of the TB21 light chains between the L-KT12 and ER cells using the MT3 light chains as a reference marker shows that the pI of the TB21 light chain of the cell line ER is more basic than that of the cell line L-KT12 (Figs. 3 and 6) , suggesting that the TB21 antigen is split into at least two structurally distinct alloantigens. The presence of the DR4 antigen in the precipitates produced with anti-TB21 sera is probably due to the contamination with a noncytotoxic DRspecific antibody, as described in the Discussion. Most of the heavy chains precipitated with anti-TB21 serum (Fig. 6C ) are considered to consist of the TB21, because the heavy chains of the MB2 and TB21 antigens are detected in much larger amounts than the light chains under the experimental conditions (Figs. 1C and 3C ) and because the amount of the DR4 heavy chain is apparently much smaller than that of the DR4 light chain (Fig. 6A) . The TB21 heavy chain precipitated with anti-TB21 serum from the ER cell (Fig. 6C ) is almost identical with the TB21 heavy chain of the L-KT12 cell on the 2-D gel (Fig. 3C) and is detected as a "slanted" spot, which seems to be characteristic of the heavy chains of the MB2 and TB21 antigens, as also observed in Figures 1C and 3C , respectively.
Discussion
To determine whether the MT3 specificity resides on a novel human class II antigen, we isolated the MT3 antigen, DR antigen, and DC-like antigen from the three DRhomozygous cell lines L-Pitot (DR7), L-KT12 (DRw9), and ER (DR4) using typing alloantisera and compared these antigens with one another by 2-D gel electrophoresis. The data obtained demonstrate that each of the MT3 and DR antigens conSists of one set of heavy and light chains in all three cell lines. As shown in the Wa cell line (DR4) in our previous study (Suzuki et al. 1983) , the data in this study also revealed that the MT3 light chain is distinct from the DR light chain in all three cell lines but that the MT3 heavy chain is indistinguishable from the DR heavy chain. These findings indicate that the MT3 specificity resides on a class II antigen distinct from the DR antigen. The data also suggest that the MT3 and DR antigens share the same heavy chain. The existence of the multiple DR-like light chains which share the same heavy chain in one DR-homozygous cell line has been shown by 2-D gel electrophoresis using murine DR-specific monomorphic determinant antibodies (Shackelford et al. 1983 , De Kretser et al. 1982a . One of these appears to be the MT3 antigen or its alMic products because (1) the MT3 antigen seems to share the heavy chain with the DR antigen and (2) some of the murine DR-specific monomorphic determinant antibodies such as L243 Levy 1980, Shackelford et al. 1983 ) also react with the MT3 antigen (unpublished data).
The MB2 (DC3) and TB21 antigens have been identified by 2-D gel electrophoresis using alloantisera in this study. The TB21 antigen is considered to be the DC-like antigen for the following reasons: (1) The TB21 specificity is closely associated with the DR4, DR5, DRw6, and DRw9 (Maeda and Juji 1982) ; therefore, it resembles the MB3 specificity. (2) The TB21 antigen is serologically different from the DR and MT3 antigens (Maeda and Juji 1982) . (3) The TB21 antigen shows limited expression on monocytes (Maeda and Juji 1982) and the DC antigens are not expressed on certain monocyte populations , Gonwa et al. 1983 . (4) A human class II antigen isolated by a monoclonal antibody (Hul8) with a specificity very similar to the anti-TB21 serum has the I-A-like amino acid sequence (Kasahara et al. 1983, Obata et al., personal communication) . The results of this study show that the light chains of both the MB2 and TB21 antigens are different in charge from the MT3 and DR light chains and that the heavy chains of both the MB2 and TB21 antigens are smaller in size and more basic in pI than the MT3 and DR heavy chains. It has been reported that the DC1 heavy chain is also smaller in The MT3 Antigen Is a Novel Human Class II Antigen 165 size than the DR heavy chain (Shackelford et al. 1981 , De Kretser et al. 1982b ). These findings indicate that the MT3 antigen is distinct from the DC-like antigen.
Alloantisera must be used to identify a given class II antigen with a supertypic specificity, since the monoclonal antibody against the alloantigenic determinant is not available for most of the class II antigens. The specificity of these alloantisera is determined by the cytotoxicity test. Therefore, the use of alloantisera has a demerit in that the alloantisera may contain noncytotoxic antibodies against different specificities. The DR antigen in the immunoprecipitate with the anti-MT3 and the anti-TB21 sera (see Figs. 1B, 3B , C, and 6C) is considered to be precipitated mainly by contaminated DR-specific antibodies for the following reason. If the MT3 or the TB21 specificity resides on the DR antigen as well as on antigen defined by the anti-MT3 or anti-TB21 sera, the ratio of the amounts of two kinds of antigen in the immunoprecipitate is probably similar to that in the whole membrane glycoproteins. In the whole membrane glycoproteins, the amount of the DR7 light chain is extremely large compared with that of the MT3 and MB2 antigens (see Fig. 2 ). Similarly, in the whole membrane glycoproteins from the cell lines L-KT 12 and ER ,~the amount of the DR antigen was extremely large compared with that of the MT3 and TB21 antigens. On the other hand, the amount of the DR light chain in the immunoprecipitate produced with the anti-MT3 or anti-TB21 serum is smaller than that of the MT3 or the TB21 antigen (Figs. 1B and 3B, C) except for the immunoprecipitate produced with the anti-TB21 serum from the cell line ER (Fig. 6C) . Even in the latter case most of the heavy chain is considered to consist of the TB21 heavy chain as described in the Results. These findings suggest that both the MT3 and TB21 specificities do not reside on the DR antigen.
It is likely that the MT3 antigen differs from the SB antigens, because no recombination between the MT3 and DR antigens has been reported yet, while the SB locus is at a distance of two centimorgans from the DR locus (Shaw et al. 1981) . Since the MT3 light chain is distinct from the light chains of the DR and the DC-like antigens and since the MT3 heavy chain seems to be identical with the DR heavy chain, the MT3 specificity appears to be located on the light chain. The findings in this study also support our previous proposition that the MT3 antigen is distinct from each of the DR, DC-like, and SB antigens and belongs to a fourth group of human class II antigens. Recent DNA analysis has shown the existence of one heavy and three light DR-like chain genes (Steinmetz et al. 1983) . Our data suggest that two of the light-chain genes may code for the DR and MT3 light chains and the heavy chain gene for the DR and MT3 heavy chain.
The frequency of the MT3 antigen is high in various populations, including Caucasian, Negro, and Japanese (Tosi 1981) . In addition, it has been observed in several diseases such as Harada's disease (Vogt-Koyanagi-Harada syndrome) and juvenile onset diabetes mellitus that the disease susceptibilities are strongly associated with the MT3 antigen (Moriuchi et al. , 1980 . Further serological and biochemical studies of the MT3 antigen and its allelic products are important to reveal their functions in the immune response. The identification of the alMic products of the MT3 antigen is now in progress in our laboratory.
